Pipeline — registered trials by phase
ASSIST Registry Studying Various Operator Techniques
— · Ischemic Stroke · Completed · est. 2022-04-11
Tornier HRS (Humeral Reconstruction System) Study (REVIVE)
— · Rheumatoid Arthritis, Osteoarthritis Shoulder, Fractures Humerus · Enrolling By Invitation · est. 2028-01-06
A Prospective Cohort Study of Basivertebral Nerve Ablation Using the Stryker OptaBlate BVN System for the Treatment of Vertebrogenic Low Back Pain
— · Verteborgenic Low Back Pain, Back Pain Lower Back · Recruiting · est. 2027-01-31
Acellular Porcine Dermal Matrix Wound Dressing in the Management of Diabetic Foot Ulcers
— · Diabetic Foot Ulcers · Completed · est. 2010-10
Perform Humeral System Study
— · Osteoarthritis Shoulder, Avascular Necrosis, Post-traumatic Arthrosis of Other Joints, Shoulder Region · Recruiting · est. 2037-06-30
A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail PF
— · Femoral Fracture · Completed · est. 2025-09-15
Mid-term Outcomes of First MTP Arthroplasty With Primus™ FGT Implant.
— · Hallux Limitus of Left Great Toe, Rheumatoid Arthritis, Arthritis of 1st Metatarsophalangeal Joint · Completed · est. 2014-06
Outcomes in Rotator Cuff Repair Using Graft Reinforcement
— · Rotator Cuff Tear · Completed · est. 2014-02
SpineJack System Postmarket Registry
— · Osteoporotic Vertebral Compression Fractures · Completed · est. 2024-11-11
Triathlon PKR Study in Japan
— · Osteoarthritis of the Knee · Completed · est. 2018-09
A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System
— · Post Traumatic Arthritis, Osteoarthritis, Total Ankle Replacement · Recruiting · est. 2030-09-30
SpO2 Accuracy of Noninvasive Disposable Pulse Oximeter Sensor With Motion Conditions
— · Healthy, Hypoxia · Completed · est. 2022-02-03
Multi MERCI (Mechanical Embolus Removal in Cerebral Ischemia [MERCI™])
— · Ischemic Stroke · Completed · est. 2006-12
Perform® Humeral System - Fracture Study (PFX)
— · Traumatic Arthropathy of Shoulder, Fracture Humerus, Traumatic Arthritis · Active Not Recruiting · est. 2026-10-01
Triathlon® Cruciate Retaining (CR) Total Knee System Outcomes Study
— · Arthroplasty, Replacement, Knee · Completed · est. 2010-04
Triathlon Total Stabilizer (TS) Outcomes Study
— · Arthroplasty, Replacement, Knee · Completed · est. 2016-04-25
A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail GT
— · Femoral Fracture · Completed · est. 2026-04-16
Retrospective Study of Suture Tape for Soft Tissue Reconstruction in Patients Suffering From Lateral Ankle Instability
— · Lateral Ankle Instability · Completed · est. 2026-04-08
Trident® Tritanium™ Acetabular Shell Revision Study
— · Arthroplasty, Replacement, Hip · Completed · est. 2016-09
The Evaluation of the METS™ Proximal Humeral System
— · Complications; Arthroplasty · Completed · est. 2016-12
Restoration® Modular Revision Hip System Post Market Study
— · Arthroplasty, Replacement, Hip · Completed · est. 2011-12
Safety and Effectiveness of an Intracranial Aneurysm Embolization System for Treating Large or Giant Wide Neck Aneurysms
— · Brain Aneurysm · Completed · est. 2016-12-11
Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter System
— · Aneurysm, Intracranial · Active Not Recruiting · est. 2025-07-14
Aequalis Pyrocarbon IDE; Replacing the Humeral Head in Hemi-Arthroplasty
— · Osteoarthritis, Avascular Necrosis, Traumatic Arthritis · Completed · est. 2019-07-19
Scorpio NRG (eNeRGize) Cruciate Retaining (CR) Post-market International Outcome Study
— · Arthroplasty, Replacement, Knee · Completed · est. 2020-02-10
A Phase 1, Double-Blind, Randomized, Single Dose Escalation Safety Study of Intra-articular OP-1 in Subjects With Osteoarthritis of the Knee
— · Osteoarthritis of the Knee · Completed
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Stryker is lead sponsor; 54 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-10-06Current report (material event)
- 10-Q2026-07-31Quarterly report
- 8-K2026-07-30Current report (material event)
- 8-K2026-06-26Current report (material event)
- SD2026-05-22SD
- 8-K2026-05-20Current report (material event)
- 10-Q2026-05-11Quarterly report
- 8-K2026-05-08Current report (material event)
- 8-K2026-04-30Current report (material event)
- SCHEDULE 13G2026-04-30SCHEDULE 13G
- SCHEDULE 13D/A2026-04-14SCHEDULE 13D/A
- 8-K/A2026-04-09Current report (amended)
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- DEFA14A2026-03-23DEFA14A
- DEF 14A2026-03-23Proxy statement
- 8-K2026-03-23Current report (material event)
- 8-K2026-03-12Current report (material event)
- 8-K2026-03-11Current report (material event)
- SCHEDULE 13G/A2026-02-11SCHEDULE 13G/A
- 10-K2026-02-11Annual report
- 8-K2026-01-29Current report (material event)
- 8-K2025-12-04Current report (material event)
- 10-Q2025-10-31Quarterly report
- 8-K2025-10-30Current report (material event)
- 10-Q2025-08-01Quarterly report
- 8-K2025-07-31Current report (material event)
- S-82025-05-30Employee stock plan
- SD2025-05-23SD
- 8-K2025-05-13Current report (material event)
- 10-Q2025-05-02Quarterly report
- 8-K2025-05-01Current report (material event)
- DEFA14A2025-03-25DEFA14A
- DEF 14A2025-03-25Proxy statement
- 8-K2025-02-27Current report (material event)
- 8-K2025-02-19Current report (material event)
- SC TO-T/A2025-02-19SC TO-T/A
- SCHEDULE 13G/A2025-02-13SCHEDULE 13G/A
- 10-K2025-02-12Annual report
- IRANNOTICE2025-02-12IRANNOTICE
- 8-K2025-02-10Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.